Efficacy and safety of 12 weeks versus 18 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin for hepatitis C virus genotype 1 infection in previously untreated patients with cirrhosis and patients with pre
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Martin Lagging Laurent Alric Edward Tam Luis A Balart |
| Publication date | November 11, 2014 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |